The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Severe enterocolitis with capecitabine (CAPE) is not a predictor of gastrointestinal (GI) toxicity with infusional 5-fluorouracil (5-FU)–based regimens: An institutional analysis.

Marie  Parish

No Relationships to Disclose

Ronald  Cox

No Relationships to Disclose

Aditya V.  Shreenivas

Consulting or Advisory Role - Taiho Pharmaceutical (Inst)

Research Funding - Natera (Inst)

Amit  Mahipal

Consulting or Advisory Role - AstraZeneca/MedImmune; QED Therapeutics; Taiho Oncology

Speakers' Bureau - AstraZeneca

Research Funding - Taiho Pharmaceutical

Sakti  Chakrabarti

Honoraria - Natera

Speakers' Bureau - Natera